| Date Filed | Type | Description |
| 03/31/2023 |
4/A
| Watanabe Todd Franklin (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 87,500 shares
@ $0
Granted 232,000 options to buy
@ $15.82, valued at
$3.7M
|
|
| 03/08/2023 |
4
| Watanabe Todd Franklin (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 2,435 shares
@ $15.2638, valued at
$37.2k
|
|
| 03/02/2023 |
4
| Watanabe Todd Franklin (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 2,343 shares
@ $16.1663, valued at
$37.9k
Sold 5,403 shares
@ $15.8182, valued at
$85.5k
Sold 69 shares
@ $16.52, valued at
$1.1k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
4
| Watanabe Todd Franklin (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,000 shares
@ $17.06, valued at
$17.1k
|
|
| 11/09/2022 |
4
| Watanabe Todd Franklin (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,000 shares
@ $18.004, valued at
$18k
|
|
| 10/11/2022 |
4
| Watanabe Todd Franklin (President and CEO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,000 shares
@ $19.51, valued at
$19.5k
|
|
| 09/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2022 |
4
| Watanabe Todd Franklin (President and CEO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,000 shares
@ $21.76, valued at
$21.8k
|
|
| 04/05/2022 |
4
| Watanabe Todd Franklin (President and CEO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,000 shares
@ $21.43, valued at
$21.4k
|
|
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
4
| Watanabe Todd Franklin (President and CEO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,000 shares
@ $17, valued at
$17k
Exercised 1,000 options to buy
@ $1.6806, valued at
$1.7k
|
|
| 01/07/2022 |
4
| Watanabe Todd Franklin (President and CEO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 300 shares
@ $22.4, valued at
$6.7k
Sold 100 shares
@ $22.06, valued at
$2.2k
Sold 600 shares
@ $21.11, valued at
$12.7k
Exercised 1,000 options to buy
@ $1.6806, valued at
$1.7k
|
|
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/09/2021 |
4
| Watanabe Todd Franklin (President and CEO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,000 shares
@ $21.5016, valued at
$21.5k
Exercised 1,000 options to buy
@ $1.6806, valued at
$1.7k
|
|
| 10/07/2021 |
4
| Watanabe Todd Franklin (President and CEO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $24.9174, valued at
$62.3k
Exercised 2,500 options to buy
@ $1.6806, valued at
$4.2k
|
|
| 10/05/2021 |
4
| Watanabe Todd Franklin (President and CEO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,500 shares
@ $25.0067, valued at
$37.5k
Exercised 1,500 options to buy
@ $1.6806, valued at
$2.5k
|
|
| 09/09/2021 |
4
| Watanabe Todd Franklin (President and CEO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,000 shares
@ $21.137, valued at
$21.1k
Exercised 1,000 options to buy
@ $1.6806, valued at
$1.7k
|
|
| 08/09/2021 |
4
| Watanabe Todd Franklin (President and CEO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,000 shares
@ $20.81, valued at
$20.8k
Exercised 1,000 options to buy
@ $1.6806, valued at
$1.7k
|
|
| 07/08/2021 |
4
| Watanabe Todd Franklin (President and CEO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,750 shares
@ $26.58, valued at
$46.5k
Exercised 1,750 options to buy
@ $1.6806, valued at
$2.9k
|
|
| 06/22/2021 |
4
| Watanabe Todd Franklin (President and CEO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Acquired 7,377 shares
@ $0 |
|
| 06/09/2021 |
4
| Watanabe Todd Franklin (President and CEO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,750 shares
@ $26.35, valued at
$46.1k
Exercised 1,750 options to buy
@ $1.6806, valued at
$2.9k
|
|
| 05/11/2021 |
4
| Watanabe Todd Franklin (President and CEO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 750 shares
@ $35, valued at
$26.3k
Exercised 750 options to buy
@ $1.6806, valued at
$1.3k
|
|
| 05/07/2021 |
4
| Watanabe Todd Franklin (President and CEO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,750 shares
@ $34, valued at
$59.5k
Exercised 1,607 options to buy
@ $1.6806, valued at
$2.7k
|
|
| 05/04/2021 |
4
| Watanabe Todd Franklin (President and CEO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,500 shares
@ $35, valued at
$52.5k
|
|
| 04/06/2021 |
4
| Watanabe Todd Franklin (President and CEO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,750 shares
@ $29.93, valued at
$52.4k
|
|
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|